chrisvoncsefalvay/vaers-outcomes huggingface dataset:
1 - redness, hot feeling, mild swelling about 3" diameter surrounding injection site, starting 1 day after shot, continuing until present time, with severe tenderness for 4 days 2 - headache starting 6 hours after shot, continuing for 4 days without stop nausea, starting 1 day after shot, continuing for 4 days without stop 3 - fever between 101.6 and 102 degrees Fahrenheit, starting 1 day after shot, continuing for 3 days, dropping to 101 for 4th day before returning to normal on 5th day 4 - chills, accompanied by uncontrollable shivering accompanying fever 5 - dizziness off and on during time of fever 6 - extreme sleepiness from 1 day after shot for 5 days No treatment, other than drinking coke in effort to prevent dehydration while being able to keep it down.
Fever and injection site pain 5 hours post injection.  Swelling and fever continue throughout the day.  Swelling and fever worsen next morning, in addition to splotchy redness.   Warm, very red, sore and swelling around 10 cm diameter from vaccine site 30 hours post injection.
Systematic Inflamation 7 days post injection. Swollen hands/feet (10 days), Hiccups, stomach cramping (no nausea or diarrhea ), neck nerve pain that went behind shoulder blade (couldn't move for 3 days), bubbles in the back off my mouth after eating (looked like big blisters filled with fluid but never popped). Low blood pressure (99/65), low body temperature with chills (95.3F), dizzy on standing, blue finger tips  loss of balance all lasting 1 day (most likely caused by mild reynod's). Subsided by day 17.
got sicker than a dog two days after shot for the third year in a row; Initial information regarding an unsolicited valid non-serious case received from a consumer (patient) via social media on 06-Dec-2020.  This case involved unknown demographic patient who got sicker than a dog two days after shot for the third year in a row (illness) while received Influenza Vaccine.  The patient's medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medication was unknown.  On an unknown date, the patient received a dose of suspect Influenza Vaccine (produced by unknown manufacturer) [lot number, expiry date and other dosing details were not reported] for prophylactic vaccination.  On an unknown date, unspecified time after receiving the vaccine, it was reported that might not be the flu but still got sicker than a dog two days after my shot for the third year in a row (illness).  It was not reported if the patient received a corrective treatment.  Outcome of the event was unknown, at the time of reporting.  There will be no information available on the batch number for this case.  The reporter assessed the causal relationship with suspect vaccine as related.
This spontaneous report was received from a medical assistant, referring to an unspecified number of patients of unknown genders and ages. No information regarding the patient's medical history, concurrent conditions or concomitant therapies was provided. On an unknown date, the patients were vaccinated with improperly stored dose of ROTATEQ with lot # M018957 and expiration date of 22-NOV-2017 and lot # M038724 with expiration date on 24-APR-2018 (strength, dose and route of administration were not reported) for prophylaxis, however no adverse effects were reported. It was reported that the vaccines were exposed to temperature of 12 Centigrade degrees (°C) range for a time frame of 24 hours. The temperature excursion was recorded by a data logger and the previous excursions were reported as 9°C to 25°C for 9 hours for the vaccines. There was no product quality complaint involved. This is one of the several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1704USA014374: US-009507513-1704USA014372: US-009507513-1704USA014373.
Right thigh warm and swollen to the size of a fist. Not fussy and no temperature.
In the week that I received the vaccine, I had what seemed like gut problems that I experience on occasion due to IBS. However, at this point, weeks later, I am so bloated that I can only wear a few items of clothing. The bloating won?t seem to let up.  The size of my abdomen has gotten progressively larger though GI problems (excessive gas, pain, and/or constipation) are infrequently present.
patient developed anaphylactic symptoms, hypotensive, dizziness, facial paleness.  Epi-pen and 1 liter NS administered.  Patient brought to ED, medicated with diphenhydramine and ondansetron.  sent home from ED after approx 4 hours.
Pt recvd 3 doses of Engerix-B on 1NOV90, 27NOV90, & 30APR91 & 7OCT91 it was determined that pts titer was neg p/3 doses of Engerix-B;
sore and swollen left arm within a couple hours,  later same day some fatigue, next day some aches, and low grade temperature.  Mild headache started suddenly around 8 hours after injection and continued for about 16 hours.
Information has been received from a medical assistant concerning unspecified patients. The patients' concomitant medications, pertinent medical history, and concurrent conditions were not provided. On 10-NOV-2016, 3 doses of improperly stored (Oka/Merck) VARIVAX (dose and frequency unknown) (lot # M014309, expiration date 21-MAR-2018, subcutaneous) were inadvertently administered to the patients. The (Oka/Merck) VARIVAX was exposed to temperature excursion of 8.6 Fahrenheit degree (F) for a time frame of 5 hours. Data logger was involved but there was no previous temperature excursion. No adverse effects were reported. This is one of several reports from the same reporter. Additional information is not expected as the reporter did not wish to further contact.
given an expired dose; This non-serious case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 56-year-old female patient who received Herpes zoster (Shingrix) (batch number AF799, expiry date 01-APR-2023) for prophylaxis.   On 05-APR-2023, the patient received the 1st dose of Shingrix. On 05-APR-2023, an unknown time after receiving Shingrix, the patient experienced expired vaccine used (Verbatim: given an expired dose). The outcome of the expired vaccine used was unknown.   Additional Information: GSK receipt date: 5-Apr-2023 The licensed practical nurse asked that the dose should be repeated. The reporter could not confirm Lot number in their system as valid. The vaccine administration facility was the same as primary reporter. The reporter did not consent to follow-up. The patient received an expired dose of Shingrix, which led to expired vaccine used.
On the morning of the third day after receiving the vaccine I woke experiencing a trigger thumb on my right hand. It has become even stiffer over the last 24 hours. The reason I am reporting this is because after receiving my second dose of the Pfizer-BioNTech vaccine in my right arm on 3/16/2021 I developed a trigger thumb on my right hand within three days after receiving the shot. At the time I wondered if it had possibly been a reaction to the vaccine. It lasted for four months until I received a steroid injection to treat it. Having it reoccur for a second time after my most recent shot I felt I should report it.
Arm pain from shoulder to elbow rated as 7 out of 10 on pain scale, headache, fatigue
Pt recvd 4 doses of Engerix-B & did not convert;
Breakthrough Dose 1: Pfizer, EN6209, 3/9/2021 Dose 2: Pfizer, ER8730, 3/30/2021 Dose 3: Moderna, No lot # given, 10/19/2021
Had WCC 7/10/09 -> Hib#2, PCV#4, VAR#1, MMR#1. Followed by febrile sz 8/6/09. Had WCC 6/7/10 -> DTAP#4, HAV#1, Hib#3. Followed by febrile sz 6/16/10. Also diagnosed w/otitis media in ER. Prescribed Amox. Hib was the only vaccine in common on both office visits.
This spontaneous report was received from a physician concerning unspecified number of patients of unknown demographics. On an unknown date, patients were vaccinated with doses of GARDASIL (lot number, expiry date, dose and route unspecified) outside of the schedule recommended. The reporter did not know exactly how many patients she had observed to receive GARDASIL outside of the schedule recommended in the product information (PI). She stated that many times, teenagers do not report to the practice to receive their scheduled second and third doses of GARDASIL. She stated that, to her knowledge, none of them experience any adverse effects. She stated that this is a typical behavior of teenagers. No concomitant therapy was reported. Additional information has been requested.
Within a minute of receiving vaccine- vision blacked out, felt faint, arms/hands/fingers stiffened and became contorted, made strange vocalizations, drooling, pushed out diaphram/ribs. This was maybe about 20 seconds and then he came to. He was sweaty and felt weak. We stayed at the doctors for about 15 min after and then left.
Itchy, swollen throat, tachycardia, nausea and headache. This happened 12 minutes after she got the shot. She was seen in the ER and discharged home.
Patient developed a fever and rash. She was seen in the ER and treated with Calamine.
pt c/o wheezing, dyspnea, and flushing. She utilized her albuterol inhaler and took benadryl 50mg PO and improved within 10 minutes or so.- pt with hx of asthma, seasonal allergies and eczema
No adverse affects reported. The patient requested an appointment to receive the Janssen Covid-19 vaccine and received the vaccine 8/9/2021. The patient deliberately did not inform the vaccinating pharmacist that he had previously received both doses of the Moderna Covid-19 vaccine in JAN/FEB 2021. We were advised by Healthmart to report to VAERS.
A grandmother reported that her grandson received second vax in series on 08/11. On 08/13, he experienced wheezing and retracting respirations. He was taken to the ER and was admitted to the hospital. He was put on IV's and received breathing treatments.
This spontaneous report as received from a pharmacist refers to a newborn male patient of unknown age. On 14-OCT-2012 10:49, the patient was vaccinated with RECOMBIVAX HB that had been exposed to temperatures below 32F for 6 hours. During that 6 hour time period, the vaccine was exposed to 28.8F for 1.5 hours. Administration route was not reported. Two lot# were involved and the lot# were reported as: 0294AE, expiry date on 06-SEP-2014; and 0385AE, expiry date on 08-NOV-2014. It was unspecified which lot# the patient was administered. The outcome of event was unknown. It was unspecified if the patient sought medical attention. This is one of several reports received from the same source. Additional information has been requested.
had the vaccine and had shingles/suspected vaccination failure; shingles/ Had shingles; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     Additional Information: GSK receipt date: 1-Mar-2023 Reporter's comment: The case was received from the patient via interactive digital media. The patient had the vaccine and had shingles. The patient thought that it would had been a worse case if he/she had not had the vaccine, but he/she was rough. Additional supportive information: This case was considered as suspected vaccination failure since the details regarding the completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.
Approximately 10 minutes after receiving her vaccine, patient was shopping with her mom and had an episode of syncope at the front cash register. She complained of dizziness and blurred vision lasting for approximately 10-15 minutes after the episode.
Dose mixed at 10:30am, expired at 4:30pm and given at 5:30pm.
Patient fully vaccinated against covid-19 and passed away on 12/13/2021 from covid-19 virus.
Pain to L deltid where sht was administered. Inability to sleep at night. Given Tylenol for pain. Weakness in L upper extremity.
Not sure it related to the shot but I started itching all over my body the night I got it. By Thursday Nov. 4th, I had a full blown sinus infection. I was sneezing, coughing, runny nose and I lost my voice.
fever for 7 days/ no appetite/ fatigue/ knot on arm the size of golf ball
Patient received 3 doses of Moderna vaccine on 12/4/21, 4/19/21, and 3/17/21.  Patient hospitalized with COVID pneumonia and severe resp failure on 1/1/22
No additional adverse effects reported.; patient received improperly stored dose of VARIVAX which was administered via unspecified route.; This spontaneous report was received from a physician refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, or medical history was provided. The concomitant therapy included sterile diluent. On 13-MAR-2020, the patient was vaccinated with improperly stored varicella virus vaccine live (oka/merck)(VARIVAX) lot # S025609 and expiration date 18-AUG-2021, for prophylaxis (dose and route of administration were not reported) which was reconstituted with properly stored sterile diluent. The administered doses of the vaccine experienced a temperature excursion of -9 degree C to 8 degree C (-5.48 degree C) for 7 hours as recorded by a data logger. The vaccine did not have any previous temperature excursions. There was no adverse effect reported. No product quality complaint was involved.
patient broke out in hives face, ears, chest and arms 24 hours after receiving vaccines. no swelling or breathing difficulties noted
3 pts vax w/ hepta B and are having side effects p/ 1st dose.  Reporter indicated "as far as I know none of the reactions are severe."
This case was reported by a healthcare professional and described the occurrence of injection site redness in a female subject of unspecified age who was vaccinated with Flulaval (GlaxoSmithKline).  On an unspecified date in 2007 (between 18 September 2007 and 02 October 20007), the subject received unspecified dose of Flulaval (0.5 ml, unknown, left arm).  On the same date as vaccination with Flulaval, the subject experienced injection site redness, injection site pruritus, and swelling injection site.  Medical attention was required at the doctor's office.  The events were resolved on the same day of vaccination/ onset of the adverse events.  The healthcare professional considered the events were probably related to vaccination with Flulaval.  The nurse reported a total of four subjects who experienced similar reactions following administrations of Flulaval between 18 September 2007 and the time of reporting on 02 October 2007 (please see GSK reference numbers A0686373A, A0686378A, and A0686380A).  "Some" of the subjects experienced "swelling at the site of injection to about softball size".  The subjects had previously received influenza vaccinations and had not experienced adverse reactions "other than one patient who may have experienced redness at injection site".
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 02-MAY-2018, the patient was vaccinated with an improperly stored dose of LIQUID PEDVAXHIB, lot # N022167, expiration date: 08-FEB-2020 (dose and route of administration were not reported). There was no adverse effect reported. Administered dose of vaccine experienced the temperature excursion of 47 to 77 degrees Fahrenheit for 5 hours. Data logger was involved. There were no previous excursions reported. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-1806USA001505: US-009507513-1806USA009026: US-009507513-1806USA009027: US-009507513-1806USA009028: US-009507513-1806USA009029: US-009507513-1806USA009030: US-009507513-1806USA009031: US-009507513-1806USA009032: US-009507513-1806USA009033: US-009507513-1806USA009034: US-009507513-1806USA009036: US-009507513-1806USA009037: US-009507513-1806USA009038: US-009507513-1806USA009039: US-009507513-1806USA009040: US-009507513-1806USA009041: US-009507513-1806USA009042: US-009507513-1806USA009043: US-009507513-1806USA009044: US-009507513-1806USA009045: US-009507513-1806USA009046: US-009507513-1806USA009047: US-009507513-1806USA009048: US-009507513-1806USA009049: US-009507513-1806USA009050: US-009507513-1806USA009051: US-009507513-1806USA009052: US-009507513-1806USA009053: US-009507513-1806USA009054: US-009507513-1806USA009055: US-009507513-1806USA009056:
Pt reported severe nasal congestion, red itchy eyes and shortness of breath with 2-3 hours of vaccine. Symptoms resolved within 5 hours. Pt used decongestant to alleviate symptoms.
I had a rheumatoid arthritis flare and my whole body joints was in pain.  These is still ongoing as of today.  I went to my Rheumatologist about this.  They put me on medicine for it.  They did blood work.
Feeling Tired; Headaches; Passed away; found dead in her bed; Was not feeling well; This is a spontaneous report from a contactable consumer. A 49-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 2 via an unspecified route of administration on 11Apr2021 (lot number: ER8729) at the age of 49 years old, as single dose for COVID-19 immunisation. The patient's medical history was not reported. Concomitant medications included naproxen sodium (NAPROSYN) taken for an unspecified indication from 05Apr2021 to an unspecified stop date; and benzonatate taken for an unspecified indication from 05Apr2021 to an unspecified stop date. The patient previously received first dose of BNT162b2 on 21Mar2021 (lot number: EP6955) at the age of 49 years old, for COVID-19 immunization and experienced fatigue, legs were hurting, dry cough, and really bad headaches. No other vaccines received in four weeks. The caller's friend (patient) got her second dose on a Sunday (11Apr2021). Monday, (12Apr2021), the patient went to work, but left because she wasn't feeling well. The reporter stated that the reporter did not speak to her friend (patient) directly on this day but was told that her friend (the patient) was feeling tired and having headaches. The reporter stated that her friend died early Tuesday morning 13Apr2021. The patient underwent lab tests and procedures which included COVID-19 PCR test: negative on 05Apr2021. The patient died on 13Apr2021. An autopsy was performed, and results were not provided. Outcome of events 'was not feeling well', 'feeling tired', and 'headaches' was unknown.; Reported Cause(s) of Death: Passed away; found dead in her bed
Vaccine that administered beyond use date after the thaw process; This spontaneous case was reported by a paramedic and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine that administered beyond use date after the thaw process) in a 22-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027H21B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 28-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 28-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine that administered beyond use date after the thaw process). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine that administered beyond use date after the thaw process) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient age was reported as 22 years 7 months.  No concomitant medication was reported. No treatment medication was reported.  On 10-Jun-2022, the vaccination facility was made aware of administration of vaccines beyond use date after the thaw process while audit was conducted. Patient got Moderna with vaccine Ndc code.  Patient was administered with a beyond use date of some lot numbers for Moderna. There was no adverse reaction noted or reported regarding this administration.
Patient reported to the pharmacy and informed me that she experienced a rash from the PNEUMOVAX 23 shot she received on Tuesday.  She said she started experiencing swelling and redness around the injection site, which was also itchy and painful.  Below the injection site she noticed a rash wrapping around her arm.  She went to her physician's office on Wednesday (3/9) to have them examine it and they felt it was an allergic reaction.  She has been taking Advil to help with the pain and swelling, while alternating with cold and heat packs on the rash area per the physician's advice.  She came into the pharmacy on Friday (3/10) to inform us about the reaction.  I examined her arm and the swelling and redness has subsided, but there was still some evidence of a rash wrapping around her arm.  I advised her to continue the Advil and the use of cold packs.
Fever, chills, restless legs, myalgias and arthralgias, left axillary and supraclavicular lymphadenopathy that started 12 hours after vaccine was given.  Fever, chills, restless legs, arthraligias and myalgias lasted 24 hours.  Axillary and supraclavicular lasted 1 week.  Tylenol 1G every 6 hours in addition to Ibuprofen 400mg BID was given with benadryl the first night, 50mg once.  I had to call into work as a physician due to the reaction related to the vaccine.
This spontaneous reports as received from a physician and from a support services director via two company representatives refers to a patient of unknown age and gender. No information regarding the patient's medical history or concurrent conditions was provided. On 29-JUN-2015, patient was vaccinated with an improperly stored dose of (wistar ra 27-3) M-M-R II injection (lot# J003625, expiry date 11-MAR-2016, albumin status HSA; dose and route of administration were not reported). There were no concomitant therapies reported. The dose of the vaccine was exposed to six separate temperature excursions (dates unspecified), all of them concerning a refrigerator: the first lasting for 168 hours with highest recorded temperature of 49 degrees Fahrenheit (9.44 degrees Celsius), the second one lasting for 336 hours with the highest recorded temperature of 59 degrees Fahrenheit (15 degrees Celsius), the third one lasting for 1172 hours with the lowest recorded temperature of -3 degrees Celsius, the fourth lasting for 80 hours with the lowest recorded temperature of 30 degrees Fahrenheit (-1.11 degrees Celsius), the fifth lasting for 416 hours with the highest recorded temperature of 47 degrees Fahrenheit (8.33 degrees Celsius) and the last lasting for 24 hours with the highest recorded temperature of 48 degrees Fahrenheit (8.89 degrees Celsius). The vaccine was stored in the refrigerator and/or in the freezer. No adverse effects were reported. There was no product quality complaint involved. This is one of several reports received from the same reporter. Additional information has been requested.
Patient had a pale episode after his first set of vaccines, resolved rapidly with color returning within 1-2 minutes, no seizure activity noted. Tolerated Hib and Prevnar at 4 months. ( Per PCP)
Fever, chills, sweats, poor appetite  Just a note: I was previously diagnosed with Covid in June 2020 wondering if that is a factor in having side effects
Redness and swelling from site of injection past elbow. Started approx 24 hours after injection given and has progressed. Denies any temp.
Needle malfunction.  Retractable HAIOU brand needle supplied with COVID supply packs.  Needle separated from syringe and plunder and remained in patient arm after injection.